{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:41:29Z","timestamp":1760924489714,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21fk0108084","JP22fk0108627"],"award-info":[{"award-number":["JP21fk0108084","JP22fk0108627"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.biologicals.2023.101677","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T18:14:34Z","timestamp":1680891274000},"page":"101677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dose-sparing effect of Sabin-derived inactivated polio vaccine produced in Japan by intradermal injection device for rats"],"prefix":"10.1016","volume":"82","author":[{"given":"Eriko","family":"Itoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakiko","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5507-7265","authenticated-orcid":false,"given":"Yasushi","family":"Ami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichiro","family":"Iwase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1654-3432","authenticated-orcid":false,"given":"Yuichi","family":"Someya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2023.101677_bib1","first-page":"16","article-title":"Circulating vaccine-derived polioviruses: current state of knowledge","volume":"82","author":"Kew","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"40","key":"10.1016\/j.biologicals.2023.101677_bib4","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1016\/j.vaccine.2014.07.065","article-title":"A national reference for inactivated polio vaccine derived from Sabin strains in Japan","volume":"32","author":"Shirato","year":"2014","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.biologicals.2023.101677_bib5","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.vaccine.2014.11.015","article-title":"Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan","volume":"34","author":"Shimizu","year":"2016","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.biologicals.2023.101677_bib6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.biologicals.2016.08.005","article-title":"Development of inactivated poliovirus vaccine from Sabin strains: a progress report","volume":"44","author":"Okayasu","year":"2016","journal-title":"Biologicals"},{"issue":"suppl_1","key":"10.1016\/j.biologicals.2023.101677_bib7","doi-asserted-by":"crossref","first-page":"S459","DOI":"10.1093\/infdis\/jiu128","article-title":"Affordable inactivated poliovirus vaccine: strategies and progress","volume":"210","author":"Okayasu","year":"2014","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.biologicals.2023.101677_bib8","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/jiy739","article-title":"Inactivated poliovirus vaccine supply shortage: is there light at the end of the tunnel?","volume":"220","author":"Sutter","year":"2019","journal-title":"J Infect Dis"},{"issue":"suppl_1","key":"10.1016\/j.biologicals.2023.101677_bib10","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1093\/infdis\/jix038","article-title":"Intradermal administration of fractional doses of inactivated poliovirus vaccine: a dose-sparing option for polio immunization","volume":"216","author":"Okayasu","year":"2017","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.biologicals.2023.101677_bib11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.vaccine.2021.12.061","article-title":"Performance and usability evaluation of novel intradermal injection device Immucise\u2122 and reanalysis of intradermal administration trials of influenza vaccine for the elderly","volume":"40","author":"Shimizu","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2023.101677_bib12","first-page":"10","article-title":"L\u2019intradermo-reaction a la tuberculine et son interpretation clinique","volume":"18","author":"Mantoux","year":"1910","journal-title":"Presse Med"},{"issue":"5","key":"10.1016\/j.biologicals.2023.101677_bib14","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1378\/chest.106.5.1463","article-title":"Influence of needle gauge in Mantoux skin testing","volume":"106","author":"Flynn","year":"1994","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.biologicals.2023.101677_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0897-1897(04)00079-5","article-title":"Intradermal injections: traditional bevel up versus bevel down","volume":"17","author":"Tarnow","year":"2004","journal-title":"Appl Nurs Res"},{"issue":"46","key":"10.1016\/j.biologicals.2023.101677_bib16","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1016\/j.vaccine.2015.09.010","article-title":"Immunogenicity and safety of the new intradermal influenza vaccine in adults and elderly: a randomized phase 1\/2 clinical trial","volume":"33","author":"Arakane","year":"2015","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.biologicals.2023.101677_bib17","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1016\/j.vaccine.2015.10.088","article-title":"Superior immunogenicity profile of the new intradermal influenza vaccine compared to the standard subcutaneous vaccine in subjects 65 years and older: a randomized controlled phase III study","volume":"33","author":"Arakane","year":"2015","journal-title":"Vaccine"},{"issue":"34","key":"10.1016\/j.biologicals.2023.101677_bib18","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1016\/j.vaccine.2007.05.046","article-title":"Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines","volume":"25","author":"Laurent","year":"2007","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.biologicals.2023.101677_bib19","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1016\/j.vaccine.2015.04.081","article-title":"Skin thickness in young infants and adolescents: applications for intradermal vaccination","volume":"33","author":"Saitoh","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2023.101677_bib20","unstructured":"International Organization for Standardization. ISO 9626:1991\/Amd 1:2001 Stainless steel needle tubing for the manufacture of medical devices \u2014 amendment 1."},{"issue":"4","key":"10.1016\/j.biologicals.2023.101677_bib21","first-page":"544","article-title":"Differences in antigenic structure of inactivated polio vaccines made from sabin live-attenuated and wild-type poliovirus strains: impact on vaccine potency assays","volume":"221","author":"Crawt","year":"2020","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.biologicals.2023.101677_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.biologicals.2006.02.010","article-title":"Development of inactivated poliovirus vaccine derived from Sabin strains","volume":"34","author":"Simizu","year":"2006","journal-title":"Biologicals"},{"year":"1992","series-title":"The Mantoux Tuberculin skin test (wall chart in color)","key":"10.1016\/j.biologicals.2023.101677_bib23"},{"issue":"17","key":"10.1016\/j.biologicals.2023.101677_bib24","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/j.vaccine.2020.03.027","article-title":"Effects of the thermal denaturation of Sabin-derived inactivated polio vaccines on the D-antigenicity and the immunogenicity in rats","volume":"38","author":"Murakami","year":"2020","journal-title":"Vaccine"},{"article-title":"Requirements for poliomyelitis vaccine (inactivated)","year":"2002","series-title":"WHO expert committee on biological standardization: fifty-first report","key":"10.1016\/j.biologicals.2023.101677_bib25"},{"article-title":"Recommendations to assure the quality, safety and efficacy of poliomyelitis vaccines (inactivated). Replacement of Annex 2 of WHO Technical Report Series, No. 910","year":"2014","series-title":"WHO expert committee on biological standardization: sixty-fifth report","key":"10.1016\/j.biologicals.2023.101677_bib26"},{"issue":"3","key":"10.1016\/j.biologicals.2023.101677_bib27","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3390\/vaccines8030534","article-title":"Vaccination into the dermal compartment: techniques, challenges, and prospects","volume":"8","author":"Hettinga","year":"2020","journal-title":"Vaccines"},{"issue":"9","key":"10.1016\/j.biologicals.2023.101677_bib28","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/infdis\/jiu624","article-title":"Intradermal inactivated poliovirus vaccine: a preclinical dose-finding study","volume":"211","author":"Kouiavskaia","year":"2015","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.biologicals.2023.101677_bib29","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1080\/21645515.2016.1214347","article-title":"Analyzed immunogenicity of fractional doses of Sabin-inactivated poliovirus vaccine (sIPV) with intradermal delivery in rats","volume":"12","author":"Ma","year":"2016","journal-title":"Hum Vaccines Immunother"},{"issue":"14","key":"10.1016\/j.biologicals.2023.101677_bib30","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.vaccine.2016.07.036","article-title":"Usability evaluation of intradermal adapters (IDA)","volume":"35","author":"Tsals","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2023.101677_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2021.102007","article-title":"Comparison of equivalent fractional vaccine doses delivered by intradermal and intramuscular or subcutaneous routes: a systematic review","volume":"41","author":"Schnyder","year":"2021","journal-title":"Trav Med Infect Dis"},{"issue":"5","key":"10.1016\/j.biologicals.2023.101677_bib32","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1080\/21645515.2020.1814094","article-title":"Subcutaneous vaccine administration\u2013an outmoded practice","volume":"17","author":"Cook","year":"2021","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.biologicals.2023.101677_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101868","article-title":"Fractional dose of intradermal compared to intramuscular and subcutaneous vaccination-A systematic review and meta-analysis","volume":"37","author":"Schnyder","year":"2020","journal-title":"Trav Med Infect Dis"},{"issue":"13","key":"10.1016\/j.biologicals.2023.101677_bib35","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMp2211311","article-title":"Intradermal vaccination for monkeypox\u2014benefits for individual and public health","volume":"387","author":"Brooks","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.biologicals.2023.101677_bib36","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1016\/j.ijid.2011.10.002","article-title":"Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines","volume":"16","author":"Cadorna-Carlos","year":"2012","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.biologicals.2023.101677_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(19)30503-3","article-title":"Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial","volume":"393","author":"Snider","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2023.101677_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.757375","article-title":"Dose-sparing intradermal DTaP-sIPV immunization with a hollow microneedle leads to superior immune responses","volume":"12","author":"Zuo","year":"2021","journal-title":"Front Microbiol"},{"issue":"22","key":"10.1016\/j.biologicals.2023.101677_bib39","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1016\/j.vaccine.2006.02.056","article-title":"Pandemic influenza preparedness: the critical role of the syringe","volume":"24","author":"Strauss","year":"2006","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.biologicals.2023.101677_bib40","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.vaccine.2016.11.098","article-title":"Vial usage, device dead space, vaccine wastage, and dose accuracy of intradermal delivery devices for inactivated poliovirus vaccine (IPV)","volume":"35","author":"Jarrahian","year":"2017","journal-title":"Vaccine"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105623000155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105623000155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:15:40Z","timestamp":1760922940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105623000155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":35,"alternative-id":["S1045105623000155"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2023.101677","relation":{},"ISSN":["1045-1056"],"issn-type":[{"type":"print","value":"1045-1056"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose-sparing effect of Sabin-derived inactivated polio vaccine produced in Japan by intradermal injection device for rats","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2023.101677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization.","name":"copyright","label":"Copyright"}],"article-number":"101677"}}